Early warning indicators and prognosis in children with fulminant myocarditis treated with extracorporeal membrane oxygenation

Ting-Ting FENG, Du-Fei ZHANG, Zhi-Xian LEI

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (6) : 702-707.

PDF(528 KB)
PDF(528 KB)
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (6) : 702-707. DOI: 10.7499/j.issn.1008-8830.2510099
CLINICAL RESEARCH

Early warning indicators and prognosis in children with fulminant myocarditis treated with extracorporeal membrane oxygenation

Author information +
History +

Abstract

Objective To explore early warning indicators for extracorporeal membrane oxygenation (ECMO) in children with fulminant myocarditis (FM) and their association with prognosis. Methods Clinical data of 22 children with FM admitted to the Pediatric Intensive Care Unit of Hainan Women and Children's Medical Center from June 2019 to June 2025 were retrospectively analyzed. Patients were grouped by ECMO support (ECMO group, n=10; non-ECMO group, n=12) and by outcome (survival group, n=17; death group, n=5). Data on demographics, laboratory values, echocardiographic measurements, and treatments administered were collected. The predictive value of early warning indicators for initiating ECMO was assessed by receiver operating characteristic (ROC) curve analysis. Results Compared with the non-ECMO group, the ECMO group had lower left ventricular ejection fraction (LVEF) and fractional shortening (FS), and higher peak brain natriuretic peptide (BNP), peak vasoactive-inotropic score (VIS), peak lactate, and a higher proportion of interventricular septal and ventricular wall hypokinesis (all P<0.05). ROC analysis showed that peak BNP >21 650 pg/mL predicted the need for ECMO with a sensitivity of 80%, specificity of 82%, positive predictive value of 80%, negative predictive value of 60%, and an area under the curve of 0.771 (P<0.05). The overall mortality was 23% (5/22). Compared with survivors, non-survivors had lower Pediatric Critical Illness Score (PCIS), LVEF, and FS, and higher peak VIS, peak lactate, lactate level at 24 hours after treatment, and a higher rate of ECMO use (all P<0.05). Conclusions Peak BNP >21 650 pg/mL has early warning value for determining the need for ECMO support in children with FM. PCIS, LVEF, FS, VIS, and lactate are useful for assessing disease severity and prognosis. ECMO is a critical life-support modality for extremely severe FM.

Key words

Fulminant myocarditis / Extracorporeal membrane oxygenation / Prognosis / Child

Cite this article

Download Citations
Ting-Ting FENG , Du-Fei ZHANG , Zhi-Xian LEI. Early warning indicators and prognosis in children with fulminant myocarditis treated with extracorporeal membrane oxygenation[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(6): 702-707 https://doi.org/10.7499/j.issn.1008-8830.2510099

References

[1]
Ammirati E, Veronese G, Bottiroli M, et al. Update on acute myocarditis[J]. Trends Cardiovasc Med, 2021, 31(6): 370-379. PMCID: PMC7263216. DOI: 10.1016/j.tcm.2020.05.008 .
[2]
Cui G, Nie J, Li H, et al. The clinicopathologic features of fulminant myocarditis[J]. J Adv Res, 2026, 81: 945-953. PMCID: PMC12957824. DOI: 10.1016/j.jare.2025.06.040 .
[3]
徐伟仙, 祖凌云. 暴发性心肌炎治疗中体外膜肺氧合的应用及进展[J]. 中国急救医学, 2021, 41(7): 616-620. DOI: 10.3969/j.issn.1002-1949.2021.07.018 .
[4]
Wrisinger WC, Thompson SL. Basics of extracorporeal membrane oxygenation[J]. Surg Clin North Am, 2022, 102(1): 23-35. PMCID: PMC8598290. DOI: 10.1016/j.suc.2021.09.001 .
[5]
中国医师协会体外生命支持专业委员会儿科学组, 中国医师协会儿童重症医师分会体外生命支持委员会, 中华医学会儿科分会急救学组, 等. 体外膜氧合支持儿科暴发性心肌炎专家共识[J]. 中华急诊医学杂志, 2020, 29(1): 36-42. DOI: 10.3760/cma.j.issn.1671-0282.2020.01.005 .
[6]
Kociol RD, Cooper LT, Fang JC, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association[J]. Circulation, 2020, 141(6): e69-e92. DOI: 10.1161/CIR.0000000000000745 .
[7]
Gaies MG, Gurney JG, Yen AH, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass[J]. Pediatr Crit Care Med, 2010, 11(2): 234-238. DOI: 10.1097/PCC.0b013e3181b806fc .
[8]
王文霞, 张慧娟, 李琳. PCIS评分联合血清NE对重症肺炎患儿预后的预测分析[J]. 齐齐哈尔医学院学报, 2023, 44(22): 2138-2141. DOI: 10.3969/j.issn.1002-1256.2023.22.008 .
[9]
刘桂良, 梁珍花, 王敏, 等. 儿童暴发性心肌炎的临床特点及体外膜肺氧合救治效果分析[J]. 中国临床新医学, 2021, 14(5): 441-445. DOI: 10.3969/j.issn.1674-3806.2021.05.04 .
[10]
Venkataraman S, Bhardwaj A, Belford PM, et al. Veno-arterial extracorporeal membrane oxygenation in patients with fulminant myocarditis: a review of contemporary literature[J]. Medicina (Kaunas), 2022, 58(2): 215. PMCID: PMC8876206. DOI: 10.3390/medicina58020215 .
[11]
Morisson L, Duceau B, Do Rego H, et al. A new machine learning algorithm to predict veno-arterial ECMO implantation after post-cardiotomy low cardiac output syndrome[J]. Anaesth Crit Care Pain Med, 2023, 42(1): 101172. DOI: 10.1016/j.accpm.2022.101172 .
[12]
Zhao Y, Da M, Yang X, et al. A retrospective analysis of clinical characteristics and outcomes of pediatric fulminant myocarditis[J]. BMC Pediatr, 2024, 24(1): 553. PMCID: PMC11360287. DOI: 10.1186/s12887-024-05022-4 .
[13]
Bak M, Hyun J, Park H, et al. Early unloading and clinical outcomes in patients with fulminant myocarditis undergoing VA-ECMO: results of a multicenter retrospective study[J]. Rev Esp Cardiol (Engl Ed), 2025, 78(3): 176-184. DOI: 10.1016/j.rec.2024.06.004 .
[14]
Nunez JI, Grandin EW, Reyes-Castro T, et al. Outcomes with peripheral venoarterial extracorporeal membrane oxygenation for suspected acute myocarditis: 10-year experience from the Extracorporeal Life Support Organization registry[J]. Circ Heart Fail, 2023, 16(7): e010152. DOI: 10.1161/CIRCHEARTFAILURE.122.010152 .
[15]
Punn R, Falkensammer CB, Blinder JJ, et al. Hemodynamic and echocardiographic predictors of mortality in pediatric patients on venoarterial extracorporeal membrane oxygenation: a multicenter investigation[J]. J Am Soc Echocardiogr, 2023, 36(2): 233-241. DOI: 10.1016/j.echo.2022.10.005 .
[16]
Zhuang SX, Shi P, Gao H, et al. Clinical characteristics and mortality risk prediction model in children with acute myocarditis[J]. World J Pediatr, 2023, 19(2): 180-188. PMCID: PMC9928813. DOI: 10.1007/s12519-022-00637-y .
[17]
Kanaoka K, Onoue K, Terasaki S, et al. Changes in cardiac function following fulminant myocarditis[J]. Circ Heart Fail, 2024, 17(4): e010840. PMCID: PMC11008446. DOI: 10.1161/CIRCHEARTFAILURE.123.010840 .
[18]
Ferro V, Pisani M, Marotta R, et al. Severe outcomes from suspected human parvovirus B19 infection in immunocompetent children: the need for timely recognition[J]. J Med Virol, 2025, 97(4): e70324. DOI: 10.1002/jmv.70324 .
[19]
Pollack BE, Barbaro RP, Gorga SM, et al. Hospital ECMO capability is associated with survival in pediatric cardiac arrest[J]. Resuscitation, 2023, 188: 109853. PMCID: PMC10576981. DOI: 10.1016/j.resuscitation.2023.109853 .

Footnotes

所有作者声明无利益冲突。

PDF(528 KB)

Accesses

Citation

Detail

Sections
Recommended

/